Last updated: March 18, 2024
Sponsor: University Gustave Eiffel
Overall Status: Active - Recruiting
Phase
N/A
Condition
Neurologic Disorders
Treatment
N/AClinical Study ID
NCT06320639
UGustaveEiffel
Ages 50-95 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosed with Neurocognitive Disorders according to the Diagnostic and StatisticalManual of Mental Disorders-V (DSM-V)
- Normal or corrected vision
- B licence holder with 3+ years driving experience
- Active drivers or drivers who stopped driving less than 2 months ago (time between themedical consultation and the day in the day care hospital)
- For participants able to give consent:
- Written informed consent to participate in the study
- Informed consent of the participant in the presence of his/her curator.
- For participants who are not able to receive information and to give consent:
- Written informed consent of the legal representative (tutor) for participantsunder tutelage.
- Signature of a relative (family member and/or trusted person) of the participant
- The participant has to be affiliated to a social security scheme.
Exclusion
Exclusion Criteria:
- History of epilepsy
- People with vestibular disorders, motion sickness or migraines
- Psychiatric history (e.g. schizophrenia)
- Non-stabilized use of antidepressants and/or anxiolytics (started or modified withinthe last 3 months)
- History of alcoholism
- Use of anti-epileptics
- Osteo-articular pathologies compromising walking
Study Design
Total Participants: 150
Study Start date:
October 03, 2023
Estimated Completion Date:
October 10, 2026
Connect with a study center
Hôpital des Charpennes
Villeurbanne, 69100
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.